Related Experiment Video
Updated: Jul 8, 2026

12:48
PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
Published on: December 27, 2013
How to achieve sustained and complete protein release from PLGA-based microparticles?
A Giteau1, M C Venier-Julienne, A Aubert-Pouëssel
1INSERM, U646, Angers F-49100, France.
International Journal of Pharmaceutics
|December 29, 2007
Summary
Achieving sustained and complete therapeutic protein release from PLGA microparticles is challenging. This review covers strategies to protect proteins from destabilization during release, ensuring therapeutic efficacy.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Protein Chemistry
Background:
- Sustained and complete release of therapeutic proteins from poly(lactic-co-glycolic acid) (PLGA) microparticles is a significant challenge in drug delivery.
- Incomplete protein release and destabilization are complex issues often evaluated through in vitro studies.
Purpose of the Study:
- To review strategies for overcoming protein destabilization during release from PLGA microparticles.
- To provide insights into protecting therapeutic proteins within microparticle formulations.
Main Methods:
- Literature review of existing strategies for protein stabilization in PLGA microparticles.
- Analysis of methods involving stabilizers, protein modification, polymer modification, and environmental control.
Main Results:
- Proteins can be protected by incorporating stabilizers into the formulation.
- Protein or polymer modification can enhance protein stability.
- Strategies exist to prevent the formation of destabilizing environments within microparticles.
Conclusions:
- Various approaches can mitigate protein destabilization and incomplete release from PLGA microparticles.
- Careful consideration of experimental conditions is crucial for accurate in vitro release studies.
- Effective strategies are essential for the successful delivery of therapeutic proteins via microparticle systems.

